1. Home
  2. CAE vs BBIO Comparison

CAE vs BBIO Comparison

Compare CAE & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAE
  • BBIO
  • Stock Information
  • Founded
  • CAE 1947
  • BBIO 2015
  • Country
  • CAE Canada
  • BBIO United States
  • Employees
  • CAE N/A
  • BBIO N/A
  • Industry
  • CAE
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAE
  • BBIO Health Care
  • Exchange
  • CAE Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • CAE 6.1B
  • BBIO 5.1B
  • IPO Year
  • CAE N/A
  • BBIO 2019
  • Fundamental
  • Price
  • CAE $23.78
  • BBIO $26.49
  • Analyst Decision
  • CAE Buy
  • BBIO Strong Buy
  • Analyst Count
  • CAE 3
  • BBIO 13
  • Target Price
  • CAE $27.33
  • BBIO $47.92
  • AVG Volume (30 Days)
  • CAE 474.0K
  • BBIO 2.7M
  • Earning Date
  • CAE 02-12-2025
  • BBIO 11-12-2024
  • Dividend Yield
  • CAE N/A
  • BBIO N/A
  • EPS Growth
  • CAE N/A
  • BBIO N/A
  • EPS
  • CAE N/A
  • BBIO N/A
  • Revenue
  • CAE $3,279,099,891.00
  • BBIO $217,765,000.00
  • Revenue This Year
  • CAE $9.13
  • BBIO $2,648.47
  • Revenue Next Year
  • CAE $7.27
  • BBIO N/A
  • P/E Ratio
  • CAE N/A
  • BBIO N/A
  • Revenue Growth
  • CAE 4.74
  • BBIO 2209.77
  • 52 Week Low
  • CAE $15.95
  • BBIO $21.62
  • 52 Week High
  • CAE $24.02
  • BBIO $44.32
  • Technical
  • Relative Strength Index (RSI)
  • CAE 64.25
  • BBIO 49.05
  • Support Level
  • CAE $22.60
  • BBIO $25.34
  • Resistance Level
  • CAE $23.85
  • BBIO $28.15
  • Average True Range (ATR)
  • CAE 0.50
  • BBIO 1.33
  • MACD
  • CAE -0.18
  • BBIO -0.24
  • Stochastic Oscillator
  • CAE 83.10
  • BBIO 24.73

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: